Table 1

Patient-level, area-level contextual and health system-level characteristics of women undergoing BCS 2002–2013, New South Wales, Australia

Variablen (%)
Total cohort34 458 (100.0)
Age (years)
 <35579 (1.7)
 35–497308 (21.2)
 50–6415 209 (44.1)
 65–799309 (27.0)
 80+2053 (6.0)
Aboriginal status
 Non-Aboriginal34 161 (99.1)
 Aboriginal297 (0.9)
Country of birth
 Australia/New Zealand23 746 (68.9)
 Europe4863 (14.1)
 East Asia2217 (6.4)
 Other2808 (8.2)
 Unknown824 (2.4)
Tumour type
 Invasive25 291 (73.4)
 In situ/in situ component9167 (26.6)
Previous breast cancer*
 No34 211 (99.3)
 Yes247 (0.7)
Other previous cancer*
 No34 169 (99.2)
 Yes289 (0.8)
No of comorbidities*
 No comorbidities31 689 (92.0)
 12303 (6.7)
 2348 (1.0)
 3+118 (0.3)
Year of initial BCS
 2002–20059868 (28.6)
 2006–200911 662 (33.8)
 2010–201312 928 (37.5)
Index of Relative Socioeconomic Disadvantage†
 Quintile 5 (least disadvantaged)12 319 (35.8)
 Quintile 47116 (20.7)
 Quintile 36860 (19.9)
 Quintile 24104 (11.9)
 Quintile 1 (most disadvantaged)4059 (11.8)
Hospital type
 Public15 516 (45.0)
 Private18 942 (55.0)
BCS surgical volume‡
 <153278 (9.5)
 15–4912 224 (35.5)
 50+18 956 (55.0)
Residential and hospital location
 Metropolitan × metropolitan23 957 (69.5)
 Metropolitan × non-metropolitan1180 (3.4)
 Non-metropolitan × metropolitan2602 (7.6)
 Non-metropolitan × non-metropolitan6719 (19.5)
  • *Recorded on or within 12 months prior to initial BCS.

  • †Index of Relative Socioeconomic Disadvantage for statistical local area of residence.

  • ‡Average annual number of BCS cases per hospital, 2002–2013.

  • BCS, breast-conserving surgery.